Deliver Your News to the World

News

Distribute Your News

  • Every day, hundreds of individuals and companies choose WebWire to distribute their news.
  • WebWire places your news within numerous highly trafficked news search engines generating leads and publicity.
  • Submit Your Release Now!

Biotechnology

Releases published in the last 30 days. RSS 0.91 Feed

Page 1 of 2

OSHA to Begin Final Rule Enforcement Actions Soon to Protect Construction Workers from Respirable Crystalline Silica
OSHA to Begin Final Rule Enforcement Actions Soon to Protect Construction Workers from Respirable Crystalline Silica
8/18/2017 8:45:42 AM
On September 23[sup]rd[/sup], the Occupational Safety and Health Administration (OSHA) is scheduled to begin enforcement actions for the new respirable crystalline silica standard for construction.
Steriflow Valve Releases White Paper on Steam in Place (SIP)
Steriflow Valve Releases White Paper on Steam in Place (SIP)
8/17/2017 8:00:00 AM
Steriflow Valve, a division of Jordan Valve, has released a white paper discussing the fundamentals of SIP, piping design and components, and the new technology available to drastically reduce these common problem occurrences.  Karl Lutkewitte, Steriflow Valve’s Product and Sales Manager, said: “Temperature validation alarms, or heat up delays, happen at some point in …
Krystyn Van Vliet named associate provost
Krystyn Van Vliet named associate provost
8/16/2017 12:50:17 PM
Krystyn Van Vliet, an MIT professor in the departments of Materials Science and Engineering and Biological Engineering, with wide-ranging interests in research and innovation, has been named as the Institute’s new associate provost.
Donor family connects gift of eye tissue to vision research
Donor family connects gift of eye tissue to vision research
8/14/2017 3:42:39 PM
When Tim Anegon became an eye tissue donor after his death in 2014, it wasn’t just one person he would touch with his eyes – it was millions. His family got a chance to see that impact in action when they visited the lab of a University of Michigan researcher whose team is putting Tim’s tissue and cells to good use.
Logic PD Announces New $9 Million Credit Facility with MB Business Capital
Logic PD Announces New $9 Million Credit Facility with MB Business Capital
8/9/2017 1:14:00 PM
Logic PD, an Electronics Manufacturing Services (EMS) and Product Development solutions company for the connected digital world, announced it has reached an agreement on a new $9 million senior credit facility with MB Business Capital, a division of MB Financial Bank, N.A.
Nanoparticles trick body into accepting organ transplants
Nanoparticles trick body into accepting organ transplants
8/4/2017 8:11:14 AM
Using nanoparticles, Yale researchers have developed a drug-delivery system that could reduce organ transplant complications by hiding the donated tissue from the recipient’s immune system.
US FDA accepts regulatory submission for acalabrutinib and grants Priority Review
US FDA accepts regulatory submission for acalabrutinib and grants Priority Review
8/3/2017 2:21:27 PM
AstraZeneca and its haematology research and development centre of excellence, Acerta Pharma, today announced that the US Food and Drug Administration (FDA) has accepted and granted Priority Review for the New Drug Application (NDA) for acalabrutinib, a highly-selective, potent, Bruton tyrosine kinase (BTK) inhibitor.
U.S. FDA Approves IMBRUVICA® (ibrutinib) as First and Only Approved Treatment for Adult Patients with Chronic Graft-Versus-Host-Disease (cGVHD) After Failure of One or More Lines of Systemic Therapy
U.S. FDA Approves IMBRUVICA® (ibrutinib) as First and Only Approved Treatment for Adult Patients with Chronic Graft-Versus-Host-Disease (cGVHD) After Failure of One or More Lines of Systemic Therapy
8/3/2017 8:31:55 AM
The U.S. Food and Drug Administration (FDA) has approved IMBRUVICA® (ibrutinib) for the treatment of adult patients with chronic graft-versus-host-disease (cGVHD) after failure of one or more lines of systemic therapy.
Good cellular neighbors combat incipient cancers
Good cellular neighbors combat incipient cancers
8/3/2017 8:23:48 AM
Scientists have spent decades studying the nature of tumor cells, but few have looked to see what was happening in the surrounding tissue.  When Yale researchers took a closer look at skin cells, they discovered the unaffected neighbor cells are not helplessly awaiting invasion of cancer cells but acting like cellular police, actively correcting tissue flaws created by their …
FDA approves treatment for chronic graft versus host disease
FDA approves treatment for chronic graft versus host disease
8/3/2017 8:11:12 AM
The U.S. Food and Drug Administration today expanded the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) after failure of one or more treatments.
Guidelines for Assessing Orthostatic Hypotension Should Be Changed, New Study Recommends
Guidelines for Assessing Orthostatic Hypotension Should Be Changed, New Study Recommends
8/1/2017 9:17:03 AM
A new study led by Johns Hopkins researchers suggests that testing for the presence of orthostatic hypotension, a form of low blood pressure, be performed within one minute of standing after a person has been lying down.
Fujifilm Announces the Launch of Two New Products for GI Endoscopic Submucosal Dissection (ESD) Procedures
Fujifilm Announces the Launch of Two New Products for GI Endoscopic Submucosal Dissection (ESD) Procedures
7/31/2017 9:00:00 AM
FUJIFILM Medical Systems U.S.A., Inc. today announced the launch of two new additions to its advanced endoscopic platform including ClutchCutter and FlushKnife devices.
Best Selling Book, “SMART HEALTH,” Is Now Free on Amazon for 5 Days (until 08/04/2017)
Best Selling Book, “SMART HEALTH,” Is Now Free on Amazon for 5 Days (until 08/04/2017)
7/31/2017 6:00:00 AM
Best Seller Publishing announces the release of Dr. Craig Koehler’s new book, “SMART HEALTH: What Today’s Doctors Aren’t Telling You.” It will be available for free download in the Amazon Kindle Store on July 31st.
Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries
Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries
7/28/2017 2:25:33 PM
Sandoz today announces the expansion of a pilot project with leading charity World Child Cancer, aimed at improving access to treatment and optimizing survival outcomes for children suffering from cancer in four developing countries.
Mandy Moore and Merck Encourage Women to Plan Ahead in Her Life. Her Adventures. Campaign
Mandy Moore and Merck Encourage Women to Plan Ahead in Her Life. Her Adventures. Campaign
7/28/2017 11:43:48 AM
Singer-songwriter and actress Mandy Moore is teaming up with Merck (NYSE:MRK), known as MSD outside the United States and Canada, to launch  Her Life.
Catherine Estrampes appointed President & CEO of GE Healthcare Europe
Catherine Estrampes appointed President & CEO of GE Healthcare Europe
7/26/2017 9:05:06 AM
Catherine Estrampes has been announced as President & CEO for GE Healthcare Europe, effective on 1 October 2017, reporting to Kieran Murphy, GE Healthcare CEO.
Abbott Initiates Clinical Trial of Three-Month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent
Abbott Initiates Clinical Trial of Three-Month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent
7/25/2017 12:16:39 PM
Abbott today announced that the first patient has been enrolled in a clinical study evaluating the short-term use of common blood thinning medicines, called dual antiplatelet therapy (DAPT), after receiving a XIENCE everolimus-eluting coronary stent.  The study, called XIENCE Short DAPT, will evaluate if three months of DAPT is non-inferior to the current standard of 12 …
ViiV Healthcare announces superior efficacy of dolutegravir versus lopinavir/ritonavir in second-line HIV treatment in resource-limited settings
ViiV Healthcare announces superior efficacy of dolutegravir versus lopinavir/ritonavir in second-line HIV treatment in resource-limited settings
7/25/2017 12:04:56 PM
ViiV Healthcare, the global specialist HIV company, majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced positive interim results from DAWNING.
Johns Hopkins Experts Available to Discuss Protecting Endangered Species Using DNA Sequencing
Johns Hopkins Experts Available to Discuss Protecting Endangered Species Using DNA Sequencing
7/25/2017 10:58:15 AM
Alan Scott, Ph.D., associate professor in the McKusick-Nathans Institute of Genetic Medicine and codirector of the Genetic Resources Core Facility at the Johns Hopkins University School of Medicine is available to comment on the recent DNA sequencing of the endangered Hawaiian monk seal, Neomonachus schauinslandi.
Evolution of pregnancy may be key to better reproductive technologies today
Evolution of pregnancy may be key to better reproductive technologies today
7/25/2017 10:11:35 AM
Pregnancy in humans has typically been studied as an anti-inflammatory process, where a mother’s immune system is suppressed to protect the fetus from attack.